JAK2 and colorectal cancer: Mechanistically, IL-6/JAK2 signaling-mediated phosphorylation of BECN1 at Y333 by contributes to chemotherapy resistance in colorectal cancer, and the pharmacological inhibition of autophagy leads to reestablishment of chemotherapy sensitivity.